Skip to main content
. 2020 Jun 9;25(6):066002. doi: 10.1117/1.JBO.25.6.066002

Fig. 1.

Fig. 1

AIFs generated by modifying (a) dose, (b) speed of injection (TTP of the AIF), and (c) the “deadspace” in the IV tubing, which causes the bolus to enter the circulatory system in two phases.